In vitro preparation and functional assessment of human monocyte-derived dendritic cells-potential antigen-specific modulators of in vivo immune responses (Q36176649)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	In vitro preparation and functional assessment of human monocyte-derived dendritic cells-potential antigen-specific modulators of in vivo immune responses	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

In vitro preparation and functional assessment of human monocyte-derived dendritic cells-potential antigen-specific modulators of in vivo immune responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

author name string

Matjaz Jeras

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Martina Bergant

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Urska Repnik

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

publication date

26 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

231-244

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Manipulating dendritic cell biology for the active immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Dendritic cells: immune regulators in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

T cell fitness determined by signal strength

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Tumour immunology, vaccination and escape strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Identification of proliferating dendritic cell precursors in mouse blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Tolerance, DCs and tryptophan: much ado about IDO

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Simple and cost-effective isolation of monocytes from buffy coats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

High-level IL-12 production by human dendritic cells requires two signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Mobilizing dendritic cells for tolerance, priming, and chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

CD4+ T cell matters in tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Clinical applications of dendritic cell vaccination in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

The induction of tolerance by dendritic cells that have captured apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Cancer immunotherapy using RNA-loaded dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Cancer immunotherapy with mRNA-transfected dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Progressive differentiation and selection of the fittest in the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

The role of in vitro alloreactive T-cell functional tests in the selection of HLA matched and mismatched haematopoietic stem cell donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Reciprocal control of T helper cell and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Dendritic-cell control of pathogen-driven T-cell polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

The antigen dose determines T helper subset development by regulation of CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.03.012

7 January 2021

Identifiers

10.1016/J.TRIM.2005.03.012

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36176649&oldid=1950040110"